Your browser doesn't support javascript.
loading
efficacy oof febuxostat and allopurinol in the treatment of gout with hyperuricemia
Pakistan Journal of Pharmaceutical Sciences. 2018; 31 (4 [special]): 1623-1627
in English | IMEMR | ID: emr-199255
ABSTRACT
The aim of this research work was to observe and analyze the efficancy of febuxostat and allopurinol in the treatment of gout with hyperuricemia. The 160 patients who has been diagnosed with gout and hyperuricemiain our hospital were selected as research objects. They were randomly divided into research group and control group, each containing 80. The control group received conventional allopurinol treatment, while the research group was treated with febuxostat. Then, the treatment efficacy was compared between the two groups. Through comparison of blood uric acid levels between the two groups after treatment, it can be known that improvement was more significant in the research group, P<0.05. The adverse reaction rate in the research group was significantly lower, P<0.05. For patients with gout and hyperuricemia, febuxostat therapy has better efficacy than that of allopurinol
Search on Google
Index: IMEMR (Eastern Mediterranean) Language: English Journal: Pak. J. Pharm. Sci. Year: 2018

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Language: English Journal: Pak. J. Pharm. Sci. Year: 2018